HAEMATO AG | |
Stock Exchange | Xetra Stock Exchange |
EPS |
EUR0.28 |
Market Cap |
EUR113.88 M |
Shares Outstanding |
22.87 M |
Public Float |
10.97 M |
Address |
Lilienthalstraße 5c Schönefeld Brandenburg 12529 Germany |
Employees | - |
Website | http://haemato.de |
Updated | 07/08/2019 |
Haemato AG engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes therapies for cancer, HIV, rheumatology, and other chronic diseases. It also consists of products for the privately financed market for aesthetic treatments. |